{"article_title": "Aetna-Humana Deal Clears Key Antitrust Hurdle But Divestitures Loom", "article_keywords": ["loom", "deal", "antitrust", "aetnahumana", "divestitures", "hurdle", "key", "clears"], "article_url": "http://www.forbes.com/sites/brucejapsen/2016/02/16/aetna-humana-deal-clears-key-antitrust-hurdle-but-divestitures-loom/", "article_text": "", "article_metadata": {"description": "Aetna said it has \u201csecured 10 of the 20 state approvals required\u201d to complete its $37 billion purchase of\u00a0Humana to form one of the nation's largest health insurance companies, but the U.S. Justice Department may still \"require divestitures,\" the company confirmed. Aetna said its latest state approval came from the state [...]", "author": "Bruce Japsen", "og": {"site_name": "Forbes", "description": "Aetna said it has \u201csecured 10 of the 20 state approvals required\u201d to complete its $37 billion purchase of\u00a0Humana to form one of the nation's largest health insurance companies, but the U.S. Justice Department may still \"require divestitures,\" the company confirmed. Aetna said its latest state approval came from the state [...]", "title": "Aetna-Humana Deal Clears Key Antitrust Hurdle But Divestitures Loom", "url": "http://www.forbes.com/sites/brucejapsen/2016/02/16/aetna-humana-deal-clears-key-antitrust-hurdle-but-divestitures-loom/", "image": "http://specials-images.forbesimg.com/imageserve/586155f14a2543ae94b42aa7d15145d1/640x434.jpg?fit=scale", "updated_time": "2016-03-28T14:52:41-04:00", "type": "article"}, "twitter": {"description": "Aetna said it has \u201csecured 10 of the 20 state approvals required\u201d to complete its $37 billion purchase of\u00a0Humana to form one of the nation's largest health insurance companies, but the U.S. Justice Department may still \"require divestitures,\" the company confirmed. Aetna said its latest state approval came from the state [...]", "creator": "@brucejapsen", "image": "http://specials-images.forbesimg.com/imageserve/586155f14a2543ae94b42aa7d15145d1/640x434.jpg?fit=scale", "title": "Aetna-Humana Deal Clears Key Antitrust Hurdle But Divestitures Loom", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Pharma and Health,Washington,Pharma &amp; Healthcare,Wall Street", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2016-03-28", "published": "2016-02-16", "id": "blogAndPostId/blog/post/2125-14580"}, "news_keywords": "Business,Pharma and Health,Washington,Pharma &amp; Healthcare,Wall Street", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "_id": "\"57477af46914bd0286fdfa98\"", "article_summary": ""}